Singapore markets open in 6 hours 45 minutes

UroGen Pharma Ltd. (URGN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.99-0.19 (-1.14%)
As of 02:13PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.85-0.86-3.59-2.71
Low estimate-0.9-0.9-3.9-3.43
High estimate-0.83-0.83-3.42-1.61
Year ago EPS-1.03-0.68-3.55-3.59
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate23.76M24.2M93.99M151.56M
Low estimate21.97M23.29M85M130.57M
High estimate25.1M25M97.86M166.3M
Year ago salesN/A20.85M82.71M93.99M
Sales growth (year/est)N/A16.10%13.60%61.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.14-0.85-0.68-0.87
Actual EPS-1.03-0.68-0.72-0.97
Difference0.110.17-0.04-0.1
Surprise %9.60%20.00%-5.90%-11.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.85-0.86-3.59-2.71
7 days ago-0.86-0.88-3.59-2.94
30 days ago-0.85-0.89-3.6-2.89
60 days ago-0.85-0.91-3.62-2.36
90 days ago-0.85-0.92-3.65-2.39
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1213
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesURGNIndustrySector(s)S&P 500
Current qtr.17.50%N/AN/AN/A
Next qtr.-26.50%N/AN/AN/A
Current year-1.10%N/AN/AN/A
Next year24.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A